The shaman and schizophrenia, revisited - Luhrmann TM, Dulin J, Dzokoto V.
This paper presents evidence that some-but not all-religious experts in a particular faith may have a schizophrenia-like psychotic process which is managed or mitigated by their religious practice, in that they are able to function effectively and are not ... (Source: SafetyLit)
Source: SafetyLit - December 4, 2023 Category: International Medicine & Public Health Tags: Risk Factor Prevalence, Injury Occurrence Source Type: news

Psychiatric Comorbidity Increases Risk for Schizophrenia With ADHD
THURSDAY, Nov. 30, 2023 -- The presence of psychiatric comorbidity in young patients with attention-deficit/hyperactivity disorder (ADHD) is associated with a higher risk for being diagnosed with schizophrenia, according to a study published online... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 30, 2023 Category: Pharmaceuticals Source Type: news

Karuna Therapeutics Announces U.S. Food and Drug Administration Accepts New Drug Application for KarXT for the Treatment of Schizophrenia
BOSTON--(BUSINESS WIRE)--Nov. 29, 2023-- Karuna Therapeutics, Inc. (NASDAQ: KRTX), a biopharmaceutical company driven to discover, develop, and deliver transformative medicines for people living with psychiatric and neurological conditions, today... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - November 29, 2023 Category: Drugs & Pharmacology Source Type: news

U.S. Suicides Hit Record High; FDA Reviews Schizophrenia Drug; Psychology of Misinfo
(MedPage Today) -- Provisional CDC estimates showed the suicide rate last year reached a record high since 1941 and was an age-adjusted 1% higher than in 2021. The FDA accepted Karuna Therapeutics' new drug application for its investigational... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - November 29, 2023 Category: Psychiatry Source Type: news

California ’ s New Plan to Treat the Mentally Ill May End Up Violating Their Rights
Facing enormous pressure to tame what appears to be a spiraling and increasingly intertwined statewide crisis in mental health, substance use, and homelessness, California officials have created the Community Assistance, Recovery and Empowerment Court, or CARE Court. The new system is a policy smorgasbord that ranges from the provision of court-ordered treatment and housing to food assistance, social activities, and exercise programming for Californians with severe mental illness. CARE Court, which launched in October to skeptical but hopeful Californians, is aimed at tackling the Golden State’s perpetual public ...
Source: TIME: Health - November 29, 2023 Category: Consumer Health News Authors: Jerel Ezell Tags: Uncategorized California Source Type: news

Association between suicidal behavior and impaired glucose metabolism in first-episode drug-na ïve patients with schizophrenia - Ma Z, Zhou HX, Chen DC, Wang DM, Zhang XY.
BACKGROUND: Schizophrenia (SZ) patients have been reported to have comorbid suicidal behavior (SB) and impaired glucose metabolism in early psychosis, but it is unclear whether impaired glucose metabolism plays a role in the occurrence of SB in patients wi... (Source: SafetyLit)
Source: SafetyLit - November 27, 2023 Category: International Medicine & Public Health Tags: Risk Factor Prevalence, Injury Occurrence Source Type: news

Othello syndrome: a case report and literature review - Abid W, Bouhamed M, Hentati S, Masmoudi R, Feki I, Sallemi R, Masmoudi J.
The Othello syndrome (OS) refers to a delusion of infidelity. It is described in the context of organic psychosis (dementia, alcoholism) or functional psychosis (schizophrenia, paranoia). There have been few case reports in the literature of OS following a... (Source: SafetyLit)
Source: SafetyLit - November 22, 2023 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

Spanish versions and validation of a series of rating scales and visual analogue scales to assess the subjective effects of cannabis - Sainz-Cort A, Mart ín-Islas M, Ona G, Jiménez-Garrido D, López-Navarro M, Muñoz-Marron E, Viejo-Sobera R, Bouso JC.
Cannabis is being legalized for medical and recreational purposes all around the world. However, the understanding of the psychological effects of cannabis is still limited, and it has been previously linked to mental disorders such as schizophrenia. Latel... (Source: SafetyLit)
Source: SafetyLit - November 22, 2023 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

Copy number variation analysis of aggressive behaviour in schizophrenia - De Luca V, Chaudhary Z, Al-Chalabi N, Qian J, Xu X, Gerretsen P, Bani-Fatemi A, Simpson A, Fischer C, Graff A, Kolla NJ.
INTRODUCTION: An increased proclivity towards violence is often associated with those diagnosed with schizophrenia (SCZ), despite contradictory findings from prior studies exploring the association between violence and SCZ. Evidence has shown that certain ... (Source: SafetyLit)
Source: SafetyLit - November 22, 2023 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news

Positive KarXT Blood Pressure Data; ADHD Manufacturing Cover-Up? 'Profound Autism'
(MedPage Today) -- Karuna Therapeutics released reassuring phase Ib data mitigating blood pressure concerns with its investigational psychiatric drug KarXT; the novel agent is under review with the FDA for an indication in schizophrenia. A Massachusetts... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - November 22, 2023 Category: Psychiatry Source Type: news

Neuromelanin-Sensitive MRI Linked to Psychosis Severity in Schizophrenia
MONDAY, Nov. 20, 2023 -- Neuromelanin-sensitive magnetic resonance imaging (NM-MRI) contrast is associated with psychosis severity in antipsychotic-free patients with schizophrenia, according to a study published online Nov. 8 in JAMA... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 20, 2023 Category: Pharmaceuticals Source Type: news

Mindfulness, psychological flexibility and their relationship with psychopathology in persons with schizophrenia-spectrum-disorders and healthy controls - a multicenter cross-sectional study - B öge K, Hallford DJ, Pillny M.
The precise nature of the relationship between mindfulness, psychological flexibility (PF) and psychopathology in schizophrenia spectrum disorders (SSD) remains largely unclear and warrants further investigation. We recruited 43 persons with SSD and 43 con... (Source: SafetyLit)
Source: SafetyLit - November 20, 2023 Category: International Medicine & Public Health Tags: Research Methods, Surveillance and Codes, Models Source Type: news

A randomized, prospective, active-controlled study comparing intramuscular long-acting paliperidone palmitate versus oral antipsychotics in patients with schizophrenia at risk of violent behavior - Wang G, Huang H, Wang Y, Yang Y, Li C, Luo S, Li Y.
This study aims to explore the effects of long-te... (Source: SafetyLit)
Source: SafetyLit - November 18, 2023 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

Association between suicidal ideation and cognitive function in young patients with schizophrenia spectrum disorder - Kim JS, Baek SH, Kim H, Kim JW, Kang HJ, Ryu S, Lee JY, Kim JM, Kim SW.
INTRODUCTION: Suicide is a major concern for patients with recent-onset schizophrenia. We hypothesized that preserved cognitive function might be associated with a higher level of suicidality in patients with schizophrenia. We investigated the associations... (Source: SafetyLit)
Source: SafetyLit - November 18, 2023 Category: International Medicine & Public Health Tags: Suicide and Self-Harm Source Type: news

New Treatment Modality May Reduce Obesity in Schizophrenia Patients
FRIDAY, Nov. 17, 2023 -- In individuals with schizophrenia, accelerated continuous theta burst stimulation (cTBS) seems promising for treating obesity, according to a study published online Oct. 31 in Schizophrenia Bulletin. Dongyu Kang, M.D., from... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 17, 2023 Category: Pharmaceuticals Source Type: news